Astellas Pharma US, Inc. , a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. , announced today that it has reached an agreement with the U.S. Department of Justice to resolve civil claims regarding the marketing of MYCAMINE for injection.
http://ift.tt/1iq8RVp
http://ift.tt/1iq8RVp
No comments:
Post a Comment